Repackaging of medicine is a hotly debated issue between pharmaceutical companies and parallel traders. Last week the CJEU published its keenly awaited judgments concerning several well-known pharmaceutical companies which provide welcome guidance. Read the article in full on BioTalk here.
| less than a minute read
To repackage or not? Latest CJEU rulings provide guidance for parallel traders of medicines

/Passle/64ef1c9c95186b4923406017/MediaLibrary/Images/2025-11-26-17-35-45-189-69273a7174601ea67c69fe4a.jpg)
/Passle/MediaLibrary/Images/2025-11-19-14-11-38-979-691dd01ad614ada1401cd306.jpg)
/Passle/MediaLibrary/Images/2025-04-25-12-04-23-729-680b7a479f65cf7abc96ca38.jpg)
/Passle/MediaLibrary/Images/2025-05-07-08-30-02-182-681b1a0a74181eb252398b03.jpg)